Throat Lozenges Market Report 2026

The throat lozenges market size has grown strongly in recent years. It will grow from $5.32 billion in 2025 to $5.62 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to high prevalence of sore throat and respiratory infections, strong reliance on otc medications, widespread availability through retail pharmacies, consumer trust in traditional lozenge formulations, seasonal flu and cold incidence.

The throat lozenges market size is expected to see strong growth in the next few years. It will grow to $7.29 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to growing health awareness among consumers, rising demand for natural and herbal remedies, expansion of e-commerce pharmacy platforms, innovation in medicated and non-medicated formulations, increasing urbanization and pollution-related throat issues. Major trends in the forecast period include rising demand for sugar-free lozenges, growing preference for herbal and natural ingredients, expansion of online pharmacy sales channels, product innovation in flavor and texture profiles, increased seasonal demand during cold and flu outbreaks.

The rising prevalence of respiratory diseases is expected to drive the growth of the throat lozenges market in the coming years. Respiratory diseases affect the lungs and other parts of the respiratory system, often causing symptoms such as sore throat, cough, and congestion. Throat lozenges help alleviate these symptoms by soothing irritation and promoting respiratory comfort. For example, in December 2023, a study published by JAMA Network Open, a medical journal of the American Medical Association, projected that global cases of chronic obstructive pulmonary disease (COPD) could reach nearly 600 million by 2050, representing a 23% increase in prevalence. As a result, the increasing incidence of respiratory diseases is contributing to the expansion of the throat lozenges market.

Leading companies in the throat lozenges market are focusing on innovative products, such as herbal formulation lozenges, to improve the effectiveness of sore throat relief while meeting growing consumer demand for natural ingredients. Herbal lozenges are valued for their soothing properties, providing relief from discomfort while offering a gentler alternative to synthetic components. For instance, in September 2024, Cipla Health Limited, an India-based pharmaceutical company, launched Cofsils Mulethi Lozenges, combining the natural taste of mulethi with herbal ingredients for fast relief from sore throats. These lozenges provide relief within five minutes using a Triple Relief Formula that integrates antiviral, antibacterial, and local anesthetic properties. Active ingredients like 2,4-amylmetacresol and dichlorobenzyl alcohol work together to soothe irritation and reduce pain effectively.

In September 2024, Dr. Reddy’s Laboratories, an India-based pharmaceutical company, acquired Haleon plc for an undisclosed amount. The acquisition aims to expand Dr. Reddy’s global presence in the nicotine replacement therapy market, diversify its OTC product portfolio with Nicotell, and strengthen its consumer healthcare offerings. The deal supports sustainable growth, aligns with WHO guidelines, and creates opportunities for future product development and revenue expansion. Haleon plc, a UK-based consumer healthcare company, produces throat lozenges under well-known brands such as Strepsils and Theraflu, offering effective relief for sore throats and coughs.

Major companies operating in the throat lozenges market are GlaxoSmithKline plc, Thornton & Ross, Reckitt Benckiser Group plc, Bliss GVS Pharma Ltd, Sanofi SA, Ricola AG, Honibe, Doetsch Grether AG, Golden Throat, Fishermans Friend, Prestige Brands Inc, HALLS, Dabur India Limited, Strepsils, Luden’s, Wedderspoon, Cepacol, Vicks, Halls Johnson, Zand Herbal, SmithKline Consumer Healthcare, Herb Pharma.

North America was the largest region in the global throat lozenges market in 2025. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the throat lozenges market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the throat lozenges market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have moderately impacted the throat lozenges market by increasing the cost of imported active ingredients, sweeteners, and specialized packaging materials, leading to higher production expenses for manufacturers. These cost pressures are most evident in menthol- and herbal-based lozenges and affect Asia-Pacific and European regions that rely heavily on cross-border ingredient sourcing. Small and mid-sized manufacturers face margin pressure, while online pharmacy pricing becomes less competitive. However, tariffs have encouraged local sourcing of raw materials and boosted domestic manufacturing, supporting regional players and supply chain resilience.

The throat lozenges market research report is one of a series of new reports that provides throat lozenges market statistics, including throat lozenges industry global market size, regional shares, competitors with a throat lozenges market share, detailed throat lozenges market segments, market trends and opportunities, and any further data you may need to thrive in the throat lozenges industry. This throat lozenges market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Throat lozenges are medicated tablets designed to dissolve in the mouth, providing relief from sore throats. They help reduce throat irritation and discomfort and often contain ingredients such as menthol or herbal extracts.

The main types of throat lozenges include hard candy lozenges, soft lozenges, and compressed lozenges. Hard candy lozenges are solid lozenges in an amorphous or glassy state, used to relieve pain in the mouth and pharynx caused by sore throats. Common ingredients in throat lozenges include menthol, mint, eucalyptus oil, peppermint oil, honey, ginger, lemon, and others. They are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels for the treatment of sore throat, cough and cold, and throat-related conditions.

The throat lozenges market consists of sales of chewable and cough drops. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.